GENIE Therapeutics, Inc. — Form D/A
GENIE Therapeutics, Inc. of WILMINGTON, DE, a company, filed a Form D amendment with the SEC on 2023-11-17. Industry: Biotechnology.
Offering
- Filed: 2023-11-17
- Form: D/A
- Accession: 0001987607-23-000002
- Industry: Biotechnology
- Exemptions: 06c
- Minimum investment: $5K
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-488093
Issuer
- Name: GENIE Therapeutics, Inc.
- CIK: 0001987607
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1207 DELAWARE AVENUE #1118, WILMINGTON, DE, 19806
- Phone: 3364166787
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Aaron Tabor | Executive Officer | Wilmington, DE |
Other filings by this issuer (1)
More